Austria's CA Immo completes sale of Belgrade's Sava Business Center
Brain Rot Comes for Italy
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC
Jill Sava
Patriarch of Serbia: St. Sava introduced our people to the mystery of the Cross and the Resurrection of Christ
I Tried the $10,000 “New Natural Psychedelic”—Here’s What Happened
Cassava Sciences (SAVA) Upgraded to Buy: What Does It Mean for the Stock?
Cassava Sciences (SAVA) Appoints New SVP of Neuroscience | SAVA Stock News
Press Release Distribution & PR Platform
Northern Colorado sexual assault support hotline disrupted during service provider switch
Sava Vemić Joins Intermusica for Management
Sava Re to provide capacity across ASR's core lines under new agreement
SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Cassava Sciences (SAVA): One of the Best Short-Term Stocks to Buy Right Now
Cassava Sciences Pivots Beyond Alzheimer's: New Leadership Eyes Breakthrough in Rare Disease Treatment
Is the Future Bleak for SAVA Stock Following Another Setback?
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study
Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT:
SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study
Failed Alzheimer's Trial Forces Cassava Sciences to Pivot: Can Their $128M Cash Cushion Fund a Comeback?
Cassava Sciences, Inc. Stockholder Alert: Robbins LLP Reminds Investors of the SAVA Class Action
SAVA Stock Plummets to 52-Week Low at $1.16 Amid Market Struggles
ASR announces Binding Authority Agreements with Sava Re
SAVA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.
$SAVA stock is up 12% today. Here's what we see in our data.
Can Simufilam Treat Rare Seizure Disorders? Yale Patent Boosts Cassava Sciences' Potential
I Slept In A $10,000 Sound Pod & I Think It Healed Me
SAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages
United Nations Provides Dredge for Sava River Project in Yugoslavia
FBI investigators seek help finding fugitives who may have fled to Florida
Sava Catlett - Men's Soccer
Major Setback: Cassava Sciences Ends Alzheimer's Program After Phase 3 Failure
Cassava Sciences: Downside From Alzheimer's Results Still Possible Despite New Developments
SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims
Cassava Sciences, Inc. Sued for Securities Law Violations –
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT:
The Gross Law Firm Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline
Tersa launches Sava Sound Pod in Europe
FBI seeks information on 2 fugitives accused in jewelry store robberies
Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops
Press Release Distribution & PR Platform
Cassava Gears Up to Report Q4 Earnings: What's in the Cards?
Cassava Sciences' Alzheimer's Drug Simufilam Fails Phase 3 Trial, Halts Studies
Cassava Sciences Cuts 33% of Workforce After Failed Alzheimer's Trial, Plans Study Closures
SAVA Lawsuit Alert! Class Action Against Cassava Sciences Inc.
Press Release Distribution & PR Platform
4 stocks to watch on Tuesday: GME, TSLA, SAVA and CCI
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops
Notable Wednesday Option Activity: UAL, ROOT, SAVA
Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge
What Makes Cassava Sciences (SAVA) a New Buy Stock
TERSA Makes Its European Debut at Four Seasons Hotel London at Tower Bridge With the Sava Sound Pod: A Revolutionary Wellness Experience
Press Release Distribution & PR Platform
Lead Plaintiff Deadline Approaching in SAVA: Kessler Topaz
Africa Specialty Risks secures Sava Re capacity
Cassava stock down as Alzheimer’s program ends (SAVA:NASDAQ)
Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA)
FBI searching for "sleight-of-hand" jewelry theft fugitives indicted in Kansas earlier this year
Press Release Distribution & PR Platform
Press Release Distribution & PR Platform
SAVA Deadline Today: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit
Cassava Sciences, Inc. Sued for Securities Law Violations –
Brinks Home names Sava Tsvetkov Chief Financial Officer
Press Release Distribution & PR Platform
ROSEN, A LEADING NATIONAL FIRM, Encourages Cassava
Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?
Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value
Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Cassava Sciences (SAVA) Announces Leadership Change Amid Future Strategy Plans
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
Press Release Distribution & PR Platform
SAVA stock touches 52-week low at $1.34 amid market challenges
Cassava Sciences (SAVA) Announces Leadership Changes with CMO Re
Cassava Sciences, Inc. Sued for Securities Law Violations –
Algae bloom turns Serbian river green
Press Release Distribution & PR Platform
SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study
Simufilam’s Collapse Leaves Cassava Searching For A Viable Future (NASDAQ:SAVA)
SAVA stock touches 52-week low at $2.15 amid market challenges
Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near?
Upgrade to hydroclimatic risk management in the Sava basin
Why I'm Avoiding Cassava Stock For Now (NASDAQ:SAVA)
SAVA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP
Shareholders of Cassava Sciences, Inc. Should Contact The
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS
16 arrests as police target migrant smuggling across the Sava River
Cassava Sciences, Inc. Sued for Securities Law Violations –
Cassava Sciences: REFOCUS Unlikely To Save Simufilam, Careful Development Needed
Ex-Socceroo star’s company pushed into liquidation
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
A new Hagia Sophia: The remarkable story of St. Sava’s Church
January 2025 Options Now Available For Cassava Sciences (SAVA)
CASSAVA SCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA
Pozavarovalnica Sava d.d's (LJSE:POSR) Upcoming Dividend Will Be Larger Than Last Year's
Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
Search for Child in Sava Continues; Woman Who Led Her into Water in Custody